Print

Molecular Response (MRL) Expands Clinical Offerings with BRAF Mutation Testing  
8/18/2011 9:13:46 AM

SAN DIEGO--(BUSINESS WIRE)--Molecular Response announced today that it has launched a clinically validated BRAF test to detect the V600E mutation in both melanoma and colorectal tumors.
//-->